Talking Rheumatology Research

Ep 50. Modifiable risk factors and therapeutic targets in polymyalgia rheumatica


Listen Later

How can we identify modifiable risk factors and new therapeutic targets in polymyalgia rheumatica?

In this episode, recorded live at BSR25, Prof Ernest Choy and Dr Steven Zhao discuss Steven's genome-wide meta-analysis and Mendelian randomisation study. They cover the key findings, which include some novel loci and potential therapeutic targets for PMR, as well as the hallmarks of a good Mendelian randomisation study. 

Further reading:

  1. Read Steven's full study in Rheumatology


Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.

Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

...more
View all episodesView all episodes
Download on the App Store

Talking Rheumatology ResearchBy British Society for Rheumatology

  • 5
  • 5
  • 5
  • 5
  • 5

5

1 ratings


More shows like Talking Rheumatology Research

View all
Rheumnow Podcast by Dr. Cush

Rheumnow Podcast

124 Listeners

The Evidence Based Rheumatology Podcast by Michael Putman

The Evidence Based Rheumatology Podcast

114 Listeners

ACR on Air by American College of Rheumatology

ACR on Air

71 Listeners

The Rest Is History by Goalhanger

The Rest Is History

13,446 Listeners

The Rest Is Politics by Goalhanger

The Rest Is Politics

3,083 Listeners

Talking Rheumatology Spotlight by British Society for Rheumatology

Talking Rheumatology Spotlight

6 Listeners

ACR Journals On Air by American College of Rheumatology

ACR Journals On Air

20 Listeners